The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 16, 2021
Filed:
Jul. 20, 2018
Yi Zheng, Cold Spring, MN (US);
Anna Zheng, Cold Spring, MN (US);
Qi Wu, ChongQing, CN;
Hui Jiang, ChongQing, CN;
Shun Zhang, ChongQing, CN;
Weining HU, Cold Spring, MN (US);
Yi Zheng, Cold Spring, MN (US);
Anna Zheng, Cold Spring, MN (US);
Qi Wu, ChongQing, CN;
Hui Jiang, ChongQing, CN;
Shun Zhang, ChongQing, CN;
Weining Hu, Cold Spring, MN (US);
Other;
Abstract
A system and method to screen for malignant gliomas, other brain tumors, and brain injuries use disturbance coefficient, differential impedances, and artificial neural networks. The system uses prescribed excitation signals with several system configurations to measure the differential impedances, calculate harmonic responses and nonlinearity of brain tissue, and estimate the disturbance coefficient that indicates the likelihood of malignant gliomas, other brain tumors, and brain injuries. The disturbance coefficient is a weighted sum of many parameters such as receiving differential impedances, transmission differential impedances, harmonic responses, frequency dispersion, and nonlinear responses using different system configurations and different excitation signals. The method includes arranging the transmitters, receivers, and transmission lines to maximize the sensitivity of detecting brain tissue condition. The artificial neural network is trained to estimate the disturbance coefficient using clinical data. The method provides a sensitive and cost effective approach for screening malignant gliomas, other brain tumors, and brain injuries.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile